These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 1840326)

  • 1. Pharmacokinetic study of etodolac after rectal administration; "in vitro" release kinetics.
    Cadorniga R; Herrero R; Barcia E; Molina IT; Guitierrez JA; Fabregas JL; Martinez-Tobed A
    Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():389-96. PubMed ID: 1840326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and drug input characteristics for a diclofenac-codeine phosphate combination following oral and rectal administration.
    Hanses A; Spahn-Langguth H; Meiss F; Mutschler E
    Arzneimittelforschung; 1996 Jan; 46(1):57-63. PubMed ID: 8821519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profile of etodolac: pharmacokinetic evaluation in special populations.
    Brater DC; Lasseter KC
    Clin Rheumatol; 1989 Mar; 8 Suppl 1():25-35. PubMed ID: 2525981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative pharmacokinetic evaluation of compressed suppositories of diclofenac sodium in humans.
    Ramakrishna S; Fadnavis NW; Diwan PV
    Arzneimittelforschung; 1996 Feb; 46(2):175-7. PubMed ID: 8720309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the effectiveness and safety of etodolac in prolonged treatment of active osteoarthritis.
    Puccetti L; Ciompi ML
    Int J Clin Pharmacol Res; 1991; 11(3):143-58. PubMed ID: 1839736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Etodolac--a new non-steroidal agent].
    Bliddal H; Kryger P
    Ugeskr Laeger; 1990 Sep; 152(36):2587-8. PubMed ID: 2144929
    [No Abstract]   [Full Text] [Related]  

  • 7. Double-blind comparison of etodolac and naproxen in the treatment of rheumatoid arthritis.
    de Queiros MF
    Clin Ther; 1991; 13(1):38-46. PubMed ID: 1827613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of etodolac in patients with stable juvenile rheumatoid arthritis.
    Boni JP; Korth-Bradley JM; Martin P; Simcoe DK; Richards LS; Rennebohm R; Walson PD
    Clin Ther; 1999 Oct; 21(10):1715-24. PubMed ID: 10566567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Open evaluation of a new anti-inflammatory analgesic drug: etodolac. Report of a clinical trial].
    Russo Frattasi CA; Bevilacqua R
    Clin Ter; 1989 May; 129(4):293-8. PubMed ID: 2527123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of etodolac enantiomers in the rat. Lack of pharmacokinetic interaction between enantiomers.
    Brocks DR; Jamali F
    Drug Metab Dispos; 1990; 18(4):471-5. PubMed ID: 1976070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological properties of the new non-steroidal anti-inflammatory agent etodolac.
    Inoue K; Fujisawa H; Sasaki Y; Nishimura T; Nishimura I; Inoue Y; Yokota M; Masuda T; Ueda F; Shibata Y
    Arzneimittelforschung; 1991 Mar; 41(3):228-35. PubMed ID: 1651085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of severity of chronic inflammatory joint disease on the pharmacokinetics of indomethacin and etodolac.
    Pawlotsky Y; Le Dantec P; Jacquelinet C; Lapicque F; Goasguen J; Perdriger A; Veillard E; Guggenbuhl P; Netter P
    Rev Rhum Engl Ed; 1996 Mar; 63(3):179-87. PubMed ID: 8731235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical trial on absorption and N-acetylation of oral and rectal mesalazine.
    Dilger K; Trenk D; Rössle M; Cap M; Zähringer A; Wacheck V; Remmler C; Cascorbi I; Kreisel W; Novacek G
    Eur J Clin Invest; 2007 Jul; 37(7):558-65. PubMed ID: 17576207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of tramadol and bioavailability of enteral tramadol formulations. 3rd Communication: suppositories.
    Lintz W; Barth H; Osterloh G; Schmidt-Böthelt E
    Arzneimittelforschung; 1998 Sep; 48(9):889-99. PubMed ID: 9793614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diclofenac and metabolite pharmacokinetics in children.
    van der Marel CD; Anderson BJ; Rømsing J; Jacqz-Aigrain E; Tibboel D
    Paediatr Anaesth; 2004 Jun; 14(6):443-51. PubMed ID: 15153204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative pharmacokinetics of ibuprofen enantiomers after rectal administration.
    Kyllönen M; Olkkola KT; Seppälä T; Ryhänen P
    Paediatr Anaesth; 2005 Jul; 15(7):566-73. PubMed ID: 15960640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind, parallel-group evaluation of etodolac and naproxen in patients with acute sports injuries.
    D'Hooghe M
    Clin Ther; 1992; 14(4):507-16. PubMed ID: 1388091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of biorelevant dissolution tests to the prediction of in vivo performance of diclofenac sodium from an oral modified-release pellet dosage form.
    Jantratid E; De Maio V; Ronda E; Mattavelli V; Vertzoni M; Dressman JB
    Eur J Pharm Sci; 2009 Jun; 37(3-4):434-41. PubMed ID: 19491035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two-way cross-over bioequivalence study comparing two products of diclofenac sodium suppositories in healthy human volunteers.
    Hasan M; Otoom S; Najib N; Sallam el-S
    Basic Clin Pharmacol Toxicol; 2004 Dec; 95(6):263-5. PubMed ID: 15569270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro and in vivo evaluations of oral sustained-release formulations of diclofenac sodium in beagle dogs.
    Medeiros DC; Mazon-Cardoso T; Lemos-Senna E; Poli A
    Pharmazie; 2009 Oct; 64(10):648-52. PubMed ID: 19947166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.